medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2021, Número 3

<< Anterior Siguiente >>

Medicina & Laboratorio 2021; 25 (3)


Evaluación de nódulos tiroideos con interpretación citológica rápida en el sitio (ROSE)

Tapia-Vela LJ, Restrepo-Giraldo L

Idioma: Español
Referencias bibliográficas: 53
Paginas: 581-591
Archivo PDF: 138.50 Kb.


RESUMEN

La aspiración con aguja fina (ACAF) es una técnica ampliamente utilizada por su alta seguridad y fácil uso. Sin embargo, al usarse en conjunto con la evaluación rápida de la muestra en el sitio de la toma (ROSE, del inglés, Rapid On- Site Evaluation), disminuyen los tiempos necesarios para la evaluación y el diagnóstico, mejora la calidad de la muestra, disminuye el número de punciones por procedimiento y limita la necesidad de repetir la prueba, lo que hace que el uso combinado de ambas técnicas sea de gran utilidad y cada vez más solicitado en los servicios de imágenes diagnósticas y patología. ROSE, además, permite una clasificación adecuada del material recolectado para cultivos, estudios de citometría de flujo y pruebas moleculares. Particularmente, en los pacientes con nódulos tiroideos, la realización de ROSE durante el procedimiento de evaluación ecográfica y punción, puede garantizar que la muestra extraída sea suficiente y adecuada para el diagnóstico, y, así mismo, permite evaluar la necesidad de estudios complementarios de manera inmediata, brindando un diagnóstico rápido y preciso, disminuyendo los costos relacionados con la repetición del procedimiento y la morbilidad asociada a complicaciones por punciones múltiples.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Díaz-Del Arco C, Ortega-Medina L, Fernández-Aceñero MJ. The role of fine-needleaspiration cytology in the diagnosis of soft tissuenodules: Experience in a tertiary center.Rev Esp Patol 2019;52:147-153. https://doi.org/10.1016/j.patol.2018.10.005.

  2. Schmidt RL, Walker BS, Cohen MB. When is rapidon-site evaluation cost-effective for fine-needleaspiration biopsy? PLoS One 2015;10:e0135466.https://doi.org/10.1371/journal.pone.0135466.

  3. Witt BL, Schmidt RL. Rapid onsite evaluationimproves the adequacy of fine-needle aspiration for thyroid lesions: a systematic reviewand meta-analysis. Thyroid 2013;23:428-435.https://doi.org/10.1089/thy.2012.0211.

  4. Ng DL, Vuhahula E, Zhang L, Waterhouse EG,White KL, Mushi BP, et al. Efficacy of an intensive,ultrasound-guided fine-needle aspirationbiopsy training workshop in Tanzania. J GlobOncol 2018;4:1-9. https://doi.org/10.1200/jgo.18.00134.

  5. Fetzer R, Duey M, Pena V, Wanzer D, KirkpatrickJ, Chau D, et al. Role of cytotechnologistsin rapid onsite adequacy assessmentof cytology materials for diagnostic workupand specimen allocation for ancillary testingusing a standardized protocol. J Am Soc Cytopathol2020;9:67-75. https://doi.org/10.1016/j.jasc.2019.08.005.

  6. Zargham R, Johnson H, Anderson S, Ciolino A.Conditions associated with the need for additionalneedle passes in ultrasound-guided thyroidfine-needle aspiration with rapid on-site pathologyevaluation. Diagn Cytopathol 2021;49:105-108. https://doi.org/10.1002/dc.24605.

  7. VanderLaan PA, Chen Y, Alex D, BalassanianR, Cuda J, Hoda RS, et al. Results fromthe 2019 American Society of Cytopathologysurvey on rapid on-site evaluation-part 1: objectivepractice patterns. J Am Soc Cytopathol2019;8:333-341. https://doi.org/10.1016/j.jasc.2019.07.007.

  8. Shield PW, Cosier J, Ellerby G, Gartrell M,Papadimos D. Rapid on-site evaluation of fineneedle aspiration specimens by cytology scientists:a review of 3032 specimens. Cytopathology2014;25:322-329. https://doi.org/10.1111/cyt.12157.

  9. Kothari K, Tummidi S, Agnihotri M, Sathe P,Naik L. This 'Rose' has no thorns-diagnostic utilityof 'rapid on-site evaluation' (ROSE) in fineneedle aspiration cytology. Indian J Surg Oncol2019;10:688-698. https://doi.org/10.1007/s13193-019-00981-y.

  10. Stevenson T, Powari M, Bowles C. Evolutionof a rapid onsite evaluation (ROSE) servicefor endobronchial ultrasound guided (EBUS)fine needle aspiration (FNA) cytology in a UKhospital: A 7 year audit. Diagn Cytopathol2018;46:656-662. https://doi.org/10.1002/dc.23967.

  11. Sauter JL, Chen Y, Alex D, Balassanian R, CudaJ, Flanagan MB, et al. Results from the 2019American Society of Cytopathology survey onrapid onsite evaluation (ROSE)-part 2: subjectiveviews among the cytopathology community.J Am Soc Cytopathol 2020;9:570-578. https://doi.org/10.1016/j.jasc.2020.06.010.

  12. Schmidt RL, Witt BL, Lopez-Calderon LE,Layfield LJ. The influence of rapid onsite evaluationon the adequacy rate of fine-needle aspirationcytology: a systematic review and meta-analysis. Am J Clin Pathol 2013;139:300-308.https://doi.org/10.1309/ajcpegzmjkc42vup.

  13. De Luca C, Sgariglia R, Nacchio M, Pisapia P,Migliatico I, Clery E, et al. Rapid on-site molecularevaluation in thyroid cytopathology: Asame-day cytological and molecular diagnosis.Diagn Cytopathol 2020;48:300-307. https://doi.org/10.1002/dc.24378.

  14. Burman KD, Wartofsky L. Clinical practice.Thyroid Nodules. N Engl J Med2015;373:2347-2356. https://doi.org/10.1056/NEJMcp1415786.

  15. Medina-Chamorro FM, Calle JA, Stein JE,Merchancano L, Mendoza-Briñez AM, Pulido-Wilches AA. Experience of the implementationof rapid on-site evaluation in ultrasound-guidedfine-needle aspiration biopsy of thyroid nodules.Curr Probl Diagn Radiol 2018;47:220-224.https://doi.org/10.1067/j.cpradiol.2017.06.009.

  16. Maxwell C, Sipos JA. Clinical diagnostic evaluationof thyroid nodules. Endocrinol MetabClin North Am 2019;48:61-84. https://doi.org/10.1016/j.ecl.2018.11.001.

  17. Grani G, Sponziello M, Pecce V, RamundoV, Durante C. Contemporary thyroid noduleevaluation and management. J Clin EndocrinolMetab 2020;105:2869-2883. https://doi.org/10.1210/clinem/dgaa322.

  18. Schlumberger M, Leboulleux S. Current practicein patients with differentiated thyroid cancer.Nat Rev Endocrinol 2021;17:176-188. https://doi.org/10.1038/s41574-020-00448-z.

  19. Vargas-Uricoechea H, Meza-Cabrera I, Herrera-Chaparro J. Concordance between theTIRADS ultrasound criteria and the BETHESDAcytology criteria on the nontoxic thyroid nodule.Thyroid Res 2017;10:1. https://doi.org/10.1186/s13044-017-0037-2.

  20. Michael CW, Kameyama K, Kitagawa W,Azar N. Rapid on-site evaluation (ROSE) forfine needle aspiration of thyroid: benefits, challengesand innovative solutions. Gland Surg2020;9:1708-1715. https://doi.org/10.21037/gs-2019-catp-23.

  21. Ahmadi S, Oyekunle T, Jiang X, Scheri R, PerkinsJ, Stang M, et al. A direct comparison ofthe ATA and TI-RADS ultrasound scoring systems.Endocr Pract 2019;25:413-422. https://doi.org/10.4158/ep-2018-0369.

  22. Melany M, Chen S. Thyroid cancer: Ultrasoundimaging and fine-needle aspiration biopsy.Endocrinol Metab Clin North Am 2017;46:691-711. https://doi.org/10.1016/j.ecl.2017.04.011.

  23. Tessler FN, Middleton WD, Grant EG, HoangJK, Berland LL, Teefey SA, et al. ACR ThyroidImaging, Reporting and Data System (TI-RADS):white paper of the ACR TI-RADS committee. JAm Coll Radiol 2017;14:587-595. https://doi.org/10.1016/j.jacr.2017.01.046.

  24. Fiore E, Rago T, Provenzale MA, Scutari M,Ugolini C, Basolo F, et al. Lower levels of TSHare associated with a lower risk of papillarythyroid cancer in patients with thyroid nodulardisease: thyroid autonomy may play a protectiverole. Endocr Relat Cancer 2009;16:1251-1260. https://doi.org/10.1677/erc-09-0036.

  25. Meller J, Becker W. The continuing importanceof thyroid scintigraphy in the era ofhigh-resolution ultrasound. Eur J Nucl MedMol Imaging 2002;29:S425-438. https://doi.org/10.1007/s00259-002-0811-8.

  26. Matthew T, Olson MAZ. Thyroid fine-needle aspirationand cytological diagnosis. In: Jameson JL,De Groot L, eds. Endocrinology: Adult and pediatric.7th ed: Elsevier; 2016. p. 1417-1422.

  27. Yang W, Fananapazir G, LaRoy J, Wilson M,Campbell MJ. Can The American Thyroid Association,K-TIRADS and ACR-TIRADS ultrasoundclassification systems be used to predict malignancyin Bethesda category IV nodules? Endocr Pract2020. https://doi.org/10.4158/ep-2020-0024.

  28. Tan GH, Gharib H. Thyroid incidentalomas:management approaches to nonpalpablenodules discovered incidentally on thyroidimaging. Ann Intern Med 1997;126:226-231.https://doi.org/10.7326/0003-4819-126-3-199702010-00009.

  29. Singaporewalla RM, Hwee J, Lang TU,Desai V. Clinico-pathological correlation ofthyroid nodule ultrasound and cytology usingthe TIRADS and Bethesda classifications.World J Surg 2017;41:1807-1811. https://doi.org/10.1007/s00268-017-3919-5.

  30. Guth S, Theune U, Aberle J, Galach A, BambergerCM. Very high prevalence of thyroidnodules detected by high frequency (13 MHz)ultrasound examination. Eur J Clin Invest2009;39:699-706. https://doi.org/10.1111/j.1365-2362.2009.02162.x.

  31. Pastorello RG, Destefani C, Pinto PH, CredidioCH, Reis RX, Rodrigues TA, et al. Theimpact of rapid on-site evaluation on thyroidfine-needle aspiration biopsy: A 2-year cancercenter institutional experience. CancerCytopathol 2018;126:846-852. https://doi.org/10.1002/cncy.22051.

  32. Haugen BR, Alexander EK, Bible KC, DohertyGM, Mandel SJ, Nikiforov YE, et al. 2015American Thyroid Association managementguidelines for adult patients with thyroid nodulesand differentiated thyroid cancer: TheAmerican Thyroid Association Guidelines TaskForce on thyroid nodules and differentiatedthyroid cancer. Thyroid 2016;26:1-133. https://doi.org/10.1089/thy.2015.0020.

  33. Detweiler K, Elfenbein DM, Mayers D. Evaluationof thyroid nodules. Surg Clin North Am2019;99:571-586. https://doi.org/10.1016/j.suc.2019.04.001.

  34. Vitagliano G, Santoro G, Landolfi L, CozzolinoI, Peluso AL, Ieni A, et al. Fine-needle cytologyof intraglandular parotid lymph node: Auseful procedure in the management of salivarygland nodules. Diagn Cytopathol 2019;47:695-700. https://doi.org/10.1002/dc.24177.

  35. Horvath L, Kraft M. Evaluation of ultrasoundand fine-needle aspiration in the assessmentof head and neck lesions. Eur Arch Otorhinolaryngol2019;276:2903-2911. https://doi.org/10.1007/s00405-019-05552-z.

  36. Sakairi Y, Nakajima T, Yoshino I. Role ofendobronchial ultrasound-guided transbronchialneedle aspiration in lung cancer management.Expert Rev Respir Med 2019;13:863-870. https://doi.org/10.1080/17476348.2019.1646642.

  37. Jain D, Allen TC, Aisner DL, Beasley MB, CaglePT, Capelozzi VL, et al. Rapid on-site evaluationof endobronchial ultrasound-guidedtransbronchial needle aspirations for the diagnosisof lung cancer: A perspective from membersof the Pulmonary Pathology Society. ArchPathol Lab Med 2018;142:253-262. https://doi.org/10.5858/arpa.2017-0114-SA.

  38. Ravaioli S, Bravaccini S, Tumedei MM,Pironi F, Candoli P, Puccetti M. Easily detectablecytomorphological features to evaluateduring ROSE for rapid lung cancerdiagnosis: from cytology to histology. Oncotarget2017;8:11199-11205. https://doi.org/10.18632/oncotarget.13204.

  39. Bilaçeroğlu S. Molecular markers in lungcancer: role of EBUS. Curr Opin Pulm Med2017;23:247-253. https://doi.org/10.1097/mcp.0000000000000376.

  40. Itonaga M, Ashida R, Kitano M. Endoscopicultrasound-guided fine-needle aspiration (EUSFNA)with image enhancement. Diagnostics2020;10:888. https://doi.org/10.3390/diagnostics10110888.

  41. Coe A, Conway J, Evans J, Goebel M, MishraG. The yield of EUS-FNA in undiagnosedupper abdominal adenopathy is very high. JClin Ultrasound 2013;41:210-213. https://doi.org/10.1002/jcu.22013.

  42. Walia S, Aron M, Hu E, Chopra S. Utility ofrapid on-site evaluation for needle core biopsiesand fine-needle aspiration cytology donefor diagnosis of mass lesions of the liver. JAm Soc Cytopathol 2019;8:69-77. https://doi.org/10.1016/j.jasc.2018.08.001.

  43. Selhi PK, Tyagi R, Bansal P, Kaur H, SoodN. Hepatic fine-needle aspiration cytology:The role of rapid on-site evaluation in the assessmentof hepatic lesions. Turk J Gastroenterol2018;29:442-447. https://doi.org/10.5152/tjg.2018.17466.

  44. Hikichi T, Irisawa A, Bhutani MS, Takagi T,Shibukawa G, Yamamoto G, et al. Endoscopicultrasound-guided fine-needle aspiration of solidpancreatic masses with rapid on-site cytologicalevaluation by endosonographers withoutattendance of cytopathologists. J Gastroenterol2009;44:322-328. https://doi.org/10.1007/s00535-009-0001-6.

  45. de Moura DTH, McCarty TR, Jirapinyo P, RibeiroIB, Hathorn KE, Madruga-Neto AC, etal. Evaluation of endoscopic ultrasound fineneedleaspiration versus fine-needle biopsyand impact of rapid on-site evaluation for pancreaticmasses. Endosc Int Open 2020;8:e738-747. https://doi.org/10.1055/a-1122-8674.

  46. Shi J, Lew M, Zalupski MM, Roh MH, KwonRS, Pang JC. Implication of suspicious cytologyin endoscopic ultrasound-guided fine-needleaspiration for pancreatic cancer. J GastrointestCanc 2015;46:54-59. https://doi.org/10.1007/s12029-014-9681-0.

  47. Ali S, Hawes RH, Kadkhodayan K, Rafiq E,Navaneethan U, Bang JY, et al. Utility of rapidonsite evaluation of touch imprint cytology fromendoscopic and cholangioscopic forceps biopsysampling (with video). Gastrointest Endosc2019;89:340-344. https://doi.org/10.1016/j.gie.2018.08.050.

  48. Lin DM, Tracht J, Rosenblum F, Kouba E, BahlD, Patel A, et al. Rapid on-site evaluation withtelecytology significantly reduced unsatisfactoryrates of thyroid fine-needle aspiration. AmJ Clin Pathol 2020;153:342-345. https://doi.org/10.1093/ajcp/aqz164.

  49. Lin O, Rudomina D, Feratovic R, SirintrapunSJ. Rapid on-site evaluation using telecytology:A major cancer center experience.Diagn Cytopathol 2019;47:15-19. https://doi.org/10.1002/dc.23925.

  50. Gutmann EJ. Something's lost, but something'sgained: On-site evaluation, telecytology, and thecytopathologist. Cancer Cytopathol 2019;127:222-224. https://doi.org/10.1002/cncy.22111.

  51. Lin O. Telecytology for rapid on-site evaluation:Current status. J Am Soc Cytopathol 2018;7:1-6. https://doi.org/10.1016/j.jasc.2017.10.002.

  52. Ohori NP, Landau MS, Manroa P, SchoedelKE, Seethala RR. Molecular-derivedestimation of risk of malignancy for indeterminatethyroid cytology diagnoses. J AmSoc Cytopathol 2020;9:213-220. https://doi.org/10.1016/j.jasc.2020.03.004.

  53. Sanchez A, Bocklage T. Precision cytopathology:expanding opportunities forbiomarker testing in cytopathology. J AmSoc Cytopathol 2019;8:95-115. https://doi.org/10.1016/j.jasc.2018.12.003.




2020     |     www.medigraphic.com